POCT Reagents of hs-cTn
High-sensitive cardiac troponin (hs-cTn) refers to the determination of cTn by a highly sensitive method. It was originally thought that cardiac troponin (cTn) was released into peripheral blood and detected after myocardial cell damage and destruction. Now a new generation of highly sensitive methods has been able to detect cTn (possibly related to the metabolism of cardiomyocytes) in a considerable part of apparently healthy people. This will help to detect small myocardial damage that was easily missed in the past, diagnose AMI earlier, screen patients at high risk of cardiovascular events (diseases) more reasonably, and optimize clinical treatment decisions and prognosis evaluation.
The cTn detected by the highly sensitive method is called hs-cTn detection. It was defined as being able to detect cTn in more than 50% of apparently healthy men and women with an imprecision (CV) of 99th URL detection ≤10%. The 2019 Guidelines for Diagnosis and Treatment of Acute Coronary Syndrome clearly stated that qualified medical institutions should prefer hs-cTn detection: if the first test result is not increased (negative), blood should be collected again at intervals of 1-3 hours and compared with the first result ; If the second test result exceeds the 99th URL and increases by more than 20%, acute myocardial injury is considered; if the initial two test results are still inconclusive and the clinical possibility of ACS is highly suspected, the test should be repeated 3-6 hours later.
Since the lowest limit of detection (LoD) of hs-cTn is reduced to 1/100~1/10 of that of traditional cTn, the accuracy of the diagnosis of myocardial injury in the first blood draw during emergency department visits is greatly improved. The negative predictive value (NPV) of a single hs-cTn detection value for myocardial infarction is > 95%, and some studies have shown that the sensitivity of 2 hs-cTn detection within 3 hours of symptom onset can reach 100% for the diagnosis of myocardial injury; therefore, For patients who seek medical attention within 3 hours from the onset of the disease, it is recommended to use the 0/1 h, 0/2 h and 0/3 h diagnosis and treatment procedures of hs-cTn to diagnose or exclude AMI, but it should be noted that the boundary value of the algorithm (cut-off value) should correspond to the detection system used; the methodology used is different, and the thresholds are also different.
Test item | hs-cTn |
Specification | 24 Test/Box for POClia |
Component | Magnetic Beads |
hs-cTn Anti | |
Substrate | |
Washing solution | |
Pipetting Tip | |
Magnetic Tube | |
Sample material | Serum |
Storage | 2-8℃ |
Other Kind of Reagents we can provide:
Thyroid | TSH |
TT3 | |
TT4 | |
FT3 | |
FT4 | |
TGAb | |
TPOAb | |
TRAb | |
TG | |
Fertility | FSH |
PRL | |
LH | |
E2 | |
TESTO | |
PROG | |
HCG | |
P/H-hcg | |
AMH | |
Glycometabolism & Hypophyseal Hormone | C-P |
INS | |
Hepatic Fibrosis | PIIINP |
HA | |
LN | |
CIV | |
Tumor Markers | CEA |
AFP | |
CA125 | |
CA19-9 | |
CA15-3 | |
CA50 | |
CA72-4 | |
CA242 | |
T-PSA | |
F-PSA | |
TK1 | |
FERRITIN | |
SCC | |
NSE | |
CYFRA21-1 | |
HE4 | |
S100 | |
Hp-Ab | |
TPS | |
TNF-α | |
GP73 | |
PIVKAⅡ | |
PACP | |
Inflammation Monitoring | IL-6 |
PCT | |
CRP | |
CAA | |
Cardiac | cTn |
MYO | |
CK-MB | |
HFABP | |
NT-pro-BNP | |
D-Dimer | |
HCY | |
BNP | |
Lp-pla2 | |
ST2 | |
TORCH | |
Infectious | HBsAg |
HBsAb | |
HBeAg | |
HBeAb | |
HBcAb | |
Anti-HCV | |
Anti-HIV | |
Anti-TP | |
NP-IgG | |
NP-IgM | |
Kidney Function | NGAL |
H-ALB | |
RBP | |
Cys-C | |
β2-MG | |
Gastric Mucosa Function | PGⅠ/Ⅱ |
PRO-GRP | |
GRP-17 |